Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02398825

Recruitment Status : Unknown

Verified October 2017 by Gruppo Italiano Malattie EMatologiche dell'Adulto.
Recruitment status was: Recruiting

First Posted : March 26, 2015

Last Update Posted : October 12, 2017

Sponsor:

Information provided by (Responsible Party):

Gruppo Italiano Malattie EMatologiche dell'Adulto

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	December 2018
Estimated Study Completion Date :	December 2020

To Top